{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T03:04:15Z","timestamp":1760151855648,"version":"build-2065373602"},"reference-count":167,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health and Welfare, Republic of China","award":["CA-110-PP-17"],"award-info":[{"award-number":["CA-110-PP-17"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The microenvironment in tumors is complicated and is constituted by different cell types and stromal proteins. Among the cell types, the abundance of cancer cells, fibroblasts, and immune cells is high and these cells work as the \u201cTrinity\u201d in promoting tumorigenesis. Although unidirectional or bidirectional crosstalk between two independent cell types has been well characterized, the multi-directional interplays between cancer cells, fibroblasts, and immune cells in vitro and in vivo are still unclear. We summarize recent studies in addressing the interaction of the \u201cTrinity\u201d members in the tumor microenvironment and propose a functional network for how these members communicate with each other. In addition, we discuss the underlying mechanisms mediating the interplay. Moreover, correlations of the alterations in the distribution and functionality of cancer cells, fibroblasts, and immune cells under different circumstances are reviewed. Finally, we point out the future application of CD8+ T cell-oriented therapy in the treatment of pancreatic cancer.<\/jats:p>","DOI":"10.3390\/biomedicines10040926","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T22:04:02Z","timestamp":1650319442000},"page":"926","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy"],"prefix":"10.3390","volume":"10","author":[{"given":"Yu-Hsuan","family":"Hung","sequence":"first","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Tzong","family":"Chen","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan"},{"name":"Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 804, Taiwan"},{"name":"Center for Cancer Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chun","family":"Hung","sequence":"additional","affiliation":[{"name":"National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.semcancer.2021.05.030","article-title":"Curing pancreatic cancer","volume":"76","author":"Traub","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1158\/1535-7163.MCT-20-1103","article-title":"Radiosensitizing Pancreatic Cancer via Effective Autophagy Inhibition","volume":"21","author":"Yazal","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/SLA.0000000000003468","article-title":"Survival Outcomes Associated with Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine\/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer","volume":"270","author":"Macedo","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"188461","DOI":"10.1016\/j.bbcan.2020.188461","article-title":"Therapeutic resistance of pancreatic cancer: Roadmap to its reversal","volume":"1875","author":"Yu","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Timmer, F.E.F., Geboers, B., Nieuwenhuizen, S., Dijkstra, M., Schouten, E.A.C., Puijk, R.S., de Vries, J.J.J., van den Tol, M.P., Bruynzeel, A.M.E., and Streppel, M.M. (2021). Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers, 13.","DOI":"10.3390\/cancers13164138"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.031","article-title":"Trials and tribulations of pancreatic cancer immunotherapy","volume":"504","author":"Principe","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bjs\/znab357","article-title":"Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival","volume":"109","author":"Kang","year":"2021","journal-title":"Br. J. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(21)00286-2","article-title":"Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: An open-label, randomised, controlled, phase 2 trial","volume":"22","author":"Zhu","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13046-018-0726-2","article-title":"Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis","volume":"37","author":"Chen","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41419-019-1956-8","article-title":"Dedifferentiation process driven by radiotherapy-induced HMGB1\/TLR2\/YAP\/HIF-1\u03b1 signaling enhances pancreatic cancer stemness","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10585-021-10142-7","article-title":"The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma","volume":"39","author":"Kawahara","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s40425-018-0448-1","article-title":"Acquired resistance to immunotherapy in MMR-D pancreatic cancer","volume":"6","author":"Hu","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2018.10.045","article-title":"Immunotherapy in pancreatic cancer: New hope or mission impossible?","volume":"445","author":"Jiang","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2021.09.022","article-title":"Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence","volume":"162","author":"Dreyer","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e153688","DOI":"10.1172\/jci.insight.153688","article-title":"Targeting the undruggable oncogenic KRAS: The dawn of hope","volume":"7","author":"Asimgil","year":"2022","journal-title":"JCI Insight"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Saiki, Y., Jiang, C., Ohmuraya, M., and Furukawa, T. (2021). Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models. Cancers, 14.","DOI":"10.3390\/cancers14010071"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"188662","DOI":"10.1016\/j.bbcan.2021.188662","article-title":"The potential roles of p53 signaling reactivation in pancreatic cancer therapy","volume":"1877","author":"Ou","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2100002","DOI":"10.1200\/PO.21.00002","article-title":"Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4\/6 Inhibition in Metastatic Breast Cancer","volume":"6","author":"Asghar","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eabc1495","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: From basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41571-021-00578-x","article-title":"Abemaciclib crowned in monarchE","volume":"19","author":"Killock","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"114109","DOI":"10.1016\/j.ejmech.2022.114109","article-title":"Recent advances in DDR (DNA damage response) inhibitors for cancer therapy","volume":"230","author":"Cheng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Prados-Carvajal, R., Irving, E., Lukashchuk, N., and Forment, J.V. (2021). Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical Landscape. Cancers, 14.","DOI":"10.3390\/cancers14010044"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1038\/s41467-020-17996-7","article-title":"Use of ratiometrically designed nanocarrier targeting CDK4\/6 and autophagy pathways for effective pancreatic cancer treatment","volume":"11","author":"Ji","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17413","DOI":"10.1021\/acs.jmedchem.1c01535","article-title":"Discovery of Potent and Novel Dual PARP\/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108707","DOI":"10.1016\/j.clim.2021.108707","article-title":"The efficacy of PD-1\/PD-L1 blockade in cold cancers and future perspectives","volume":"226","author":"Majidpoor","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mc.23179","article-title":"Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy","volume":"59","author":"Torphy","year":"2020","journal-title":"Mol. Carcinog."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wandmacher, A.M., Letsch, A., and Sebens, S. (2021). Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13164235"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Saka, D., G\u00f6kalp, M., Piyade, B., Cevik, N.C., Arik Sever, E., Unutmaz, D., Ceyhan, G.O., Demir, I.E., and Asimgil, H. (2020). Mechanisms of T-Cell Exhaustion in Pancreatic Cancer. Cancers, 12.","DOI":"10.3390\/cancers12082274"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jcmgh.2021.07.006","article-title":"Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer","volume":"12","author":"Kemp","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.trecan.2019.09.010","article-title":"CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer","volume":"5","author":"Pereira","year":"2019","journal-title":"Trends Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2021.02.012","article-title":"Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts","volume":"172","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sunami, Y., H\u00e4u\u00dfler, J., and Kleeff, J. (2020). Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer. Cancers, 12.","DOI":"10.3390\/cancers12123770"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.7150\/thno.26546","article-title":"The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer","volume":"8","author":"Sun","year":"2018","journal-title":"Theranostics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","article-title":"Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment","volume":"10","author":"Helms","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","article-title":"Cancer-associated fibroblasts: Overview, progress, challenges, and directions","volume":"28","author":"Ping","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2018-316451","article-title":"Stromal biology and therapy in pancreatic cancer: Ready for clinical translation?","volume":"68","author":"Neesse","year":"2019","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"Biffi","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1158\/0008-5472.CAN-15-3264","article-title":"Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation","volume":"76","author":"Xiao","year":"2016","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT Signaling Is Antagonized by TGF\u03b2 to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.5224","article-title":"Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma","volume":"248","author":"Neuzillet","year":"2019","journal-title":"J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.2001203","article-title":"Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes","volume":"206","author":"Baker","year":"2021","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"C233","DOI":"10.1152\/ajpcell.00079.2020","article-title":"Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer","volume":"319","author":"Huang","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Norton, J., Foster, D., Chinta, M., Titan, A., and Longaker, M. (2020). Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment. Cancers, 12.","DOI":"10.3390\/cancers12051347"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3748\/wjg.v27.i18.2105","article-title":"Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects","volume":"27","author":"Polani","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Carstens","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-20-3715","article-title":"Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","article-title":"Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ccell.2021.05.010","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Strating, E., Wassenaar, E., Verhagen, M., Rauwerdink, P., van Schelven, S., de Hingh, I., Rinkes, I.B., Boerma, D., Witkamp, A., and Lacle, M. (2022). Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by (68)Ga-FAPI-PET imaging. Br. J. Cancer.","DOI":"10.1038\/s41416-022-01748-z"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ganguly, K., Shah, A., Atri, P., Rauth, S., Ponnusamy, M.P., Kumar, S., and Batra, S.K. (2022). Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2022.03.022"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: An update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1158\/1078-0432.CCR-20-3925","article-title":"Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies","volume":"27","author":"Lee","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Domen, A., Quatannens, D., Zanivan, S., Deben, C., Van Audenaerde, J., Smits, E., Wouters, A., Lardon, F., Roeyen, G., and Verhoeven, Y. (2021). Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13050987"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gorchs, L., and Kaipe, H. (2021). Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines. Cancers, 13.","DOI":"10.3390\/cancers13122995"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Boyd, L.N.C., Andini, K.D., Peters, G.J., Kazemier, G., and Giovannetti, E. (2021). Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment. Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2021.03.006"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"655152","DOI":"10.3389\/fcell.2021.655152","article-title":"Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer","volume":"9","author":"Geng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Vaish, U., Jain, T., Are, A.C., and Dudeja, V. (2021). Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413408"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.04.003","article-title":"Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review","volume":"189","author":"Roeyen","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2020.10.029","article-title":"Macrophages in pancreatic cancer: An immunometabolic perspective","volume":"498","author":"Yang","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gan, L.L., Hii, L.W., Wong, S.F., Leong, C.O., and Mai, C.W. (2020). Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion. Cancers, 12.","DOI":"10.3390\/cancers12071872"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/cgt.2016.65","article-title":"Myeloid-derived suppressor cells and their role in pancreatic cancer","volume":"24","author":"Pergamo","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"605619","DOI":"10.3389\/fimmu.2020.605619","article-title":"Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer","volume":"11","author":"Vonderheide","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e001100","DOI":"10.1136\/jitc-2020-001100","article-title":"Mirage or long-awaited oasis: Reinvigorating T-cell responses in pancreatic cancer","volume":"8","author":"Ware","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-019-0966-6","article-title":"TAMing pancreatic cancer: Combat with a double edged sword","volume":"18","author":"Lankadasari","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3748\/wjg.v27.i24.3483","article-title":"Natural killer cells in pancreatic cancer stroma","volume":"27","author":"Fincham","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejca.2020.03.013","article-title":"The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: A systematic review and meta-analysis","volume":"132","author":"Orhan","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jare.2020.03.009","article-title":"The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma","volume":"24","author":"Xu","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcibr0801519","article-title":"Mast cells and pancreatic cancer","volume":"358","author":"Theoharides","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e25964","DOI":"10.4161\/onci.25964","article-title":"Intratumoral mast cells promote the growth of pancreatic cancer","volume":"2","author":"Ma","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10238-018-0493-6","article-title":"Mast cells and angiogenesis in pancreatic ductal adenocarcinoma","volume":"18","author":"Longo","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2017.12.009","article-title":"A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection","volume":"20","author":"Mowbray","year":"2018","journal-title":"HPB"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2018.01.024","article-title":"Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients","volume":"479","author":"Zhou","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.2147\/CMAR.S196951","article-title":"Prognostic value of tumor-associated macrophages in pancreatic cancer: A meta-analysis","volume":"11","author":"Yu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1067\/msy.2002.119937","article-title":"Paucity of dendritic cells in pancreatic cancer","volume":"131","author":"Dallal","year":"2002","journal-title":"Surgery"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00262-011-1023-5","article-title":"Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: Results of a pilot study","volume":"60","author":"Bauer","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1084\/jem.20111706","article-title":"MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells","volume":"209","author":"Ochi","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00262-014-1554-7","article-title":"Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: A multicenter analysis","volume":"63","author":"Kobayashi","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cas.12621","article-title":"Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer","volume":"106","author":"Mayanagi","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4292\/wjgpt.v7.i1.133","article-title":"Dendritic cell-based vaccine for pancreatic cancer in Japan","volume":"7","author":"Okamoto","year":"2016","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcyt.2019.12.001","article-title":"Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model","volume":"22","author":"Shangguan","year":"2020","journal-title":"Cytotherapy"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trecan.2017.12.007","article-title":"Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment","volume":"4","author":"Saxena","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/cac2.12156","article-title":"The role of myeloid-derived suppressor cells in gastrointestinal cancer","volume":"41","author":"Cui","year":"2021","journal-title":"Cancer Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s40425-019-0734-6","article-title":"Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3","volume":"7","author":"Trovato","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fphar.2020.00576","article-title":"Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3389\/fimmu.2020.01963","article-title":"Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity","volume":"11","author":"Kramer","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Krishnamoorthy, M., Lenehan, J.G., Burton, J.P., and Maleki Vareki, S. (2020). Immunomodulation in Pancreatic Cancer. Cancers, 12.","DOI":"10.3390\/cancers12113340"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e2020395118","DOI":"10.1073\/pnas.2020395118","article-title":"IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions","volume":"118","author":"Mucciolo","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccr.2014.03.014","article-title":"Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia","volume":"25","author":"McAllister","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/s41467-020-19288-6","article-title":"Immune modulatory effects of oncogenic KRAS in cancer","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3389\/fimmu.2018.01611","article-title":"IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis","volume":"9","author":"Park","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e20190354","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s40425-019-0757-z","article-title":"IL-17 inhibits CXCL9\/10-mediated recruitment of CD8(+) cytotoxic T cells and regulatory T cells to colorectal tumors","volume":"7","author":"Chen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1758606","DOI":"10.1080\/2162402X.2020.1758606","article-title":"IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8(+) T-cell responses","volume":"9","author":"Dadaglio","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/2159-8290.CD-19-0958","article-title":"Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1038\/onc.2010.261","article-title":"HMGB1 release and redox regulates autophagy and apoptosis in cancer cells","volume":"29","author":"Tang","year":"2010","journal-title":"Oncogene"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/cam4.993","article-title":"Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma","volume":"6","author":"Zhang","year":"2017","journal-title":"Cancer Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1091\/mbc.e12-03-0172","article-title":"ECM stiffness primes the TGF\u03b2 pathway to promote chondrocyte differentiation","volume":"23","author":"Allen","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Huber, M., Brehm, C.U., Gress, T.M., Buchholz, M., Alashkar Alhamwe, B., von Strandmann, E.P., Slater, E.P., Bartsch, J.W., Bauer, C., and Lauth, M. (2020). The Immune Microenvironment in Pancreatic Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197307"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fendo.2015.00159","article-title":"The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Endocrinol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Tirpe, A., Gulei, D., Tirpe, G.R., Nutu, A., Irimie, A., Campomenosi, P., Pop, L.A., and Berindan-Neagoe, I. (2020). Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218002"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1021\/acsnano.8b02481","article-title":"Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer","volume":"12","author":"Zhao","year":"2018","journal-title":"ACS Nano"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"eabb6596","DOI":"10.1126\/sciadv.abb6596","article-title":"Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2019.02.005","article-title":"Relaxin and fibrosis: Emerging targets, challenges, and future directions","volume":"487","author":"Kanai","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2019.00847","article-title":"Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4(+) and CD8(+) T-Cells","volume":"10","author":"Gorchs","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2020.00297","article-title":"Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis","volume":"11","author":"Ireland","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Tanaka, M., and Siemann, D.W. (2020). Gas6\/Axl Signaling Pathway in the Tumor Immune Microenvironment. Cancers, 12.","DOI":"10.3390\/cancers12071850"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e2024596118","DOI":"10.1073\/pnas.2024596118","article-title":"The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion","volume":"118","author":"Kozik","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Kamionka, E.M., Qian, B., Gross, W., Bergmann, F., Hackert, T., Beretta, C.A., Dross, N., and Ryschich, E. (2021). Collagen Organization Does Not Influence T-Cell Distribution in Stroma of Human Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13153648"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Lawal, B., Lin, L.C., Lee, J.C., Chen, J.H., Bekaii-Saab, T.S., Wu, A.T.H., and Ho, C.L. (2021). Multi-Omics Data Analysis of Gene Expressions and Alterations, Cancer-Associated Fibroblast and Immune Infiltrations, Reveals the Onco-Immune Prognostic Relevance of STAT3\/CDK2\/4\/6 in Human Malignancies. Cancers, 13.","DOI":"10.3390\/cancers13050954"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"MacNeil, T., Vathiotis, I.A., Shafi, S., Aung, T.N., Zugazagoitia, J., Gruver, A.M., Driscoll, K., and Rimm, D.L. (2021). Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13215501"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.1038\/s41598-021-91796-x","article-title":"Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer","volume":"11","author":"Tahkola","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MPA.0000000000001261","article-title":"Desmoplasia in Lymph Node Metastasis of Pancreatic Adenocarcinoma Reveals Activation of Cancer-Associated Fibroblasts Pattern and T-helper 2 Immune Cell Infiltration","volume":"48","author":"Nizri","year":"2019","journal-title":"Pancreas"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"643529","DOI":"10.3389\/fimmu.2021.643529","article-title":"Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer","volume":"12","author":"Sadozai","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/1535-7163.MCT-18-0850","article-title":"TGF\u03b2 Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer","volume":"18","author":"Principe","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8(+) T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: The COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1002\/cti2.1165","article-title":"Novel combination immunotherapy for pancreatic cancer: Potent anti-tumor effects with CD40 agonist and interleukin-15 treatment","volume":"9","author":"Marcq","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"eaau9240","DOI":"10.1126\/scitranslmed.aau9240","article-title":"Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies","volume":"11","author":"Panni","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-019-12657-w","article-title":"The TLR7\/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer","volume":"10","author":"Michaelis","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/2326-6066.CIR-20-0272","article-title":"Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance","volume":"9","author":"Ajina","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10555-021-09988-w","article-title":"The tumor microenvironment in pancreatic ductal adenocarcinoma: Current perspectives and future directions","volume":"40","author":"Herting","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/fon-2018-0903","article-title":"CanStem111P trial: A Phase III study of napabucasin plus nab-paclitaxel with gemcitabine","volume":"15","author":"Sonbol","year":"2019","journal-title":"Future Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2468-1253(18)30009-8","article-title":"Napabucasin versus placebo in refractory advanced colorectal cancer: A randomised phase 3 trial","volume":"3","author":"Jonker","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10147-021-01987-9","article-title":"Phase I study of napabucasin in combination with FOLFIRI\u2009+\u2009bevacizumab in Japanese patients with metastatic colorectal cancer","volume":"26","author":"Taniguchi","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1182\/blood-2013-12-546374","article-title":"Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti\u2013IL-6) in multiple myeloma","volume":"123","author":"Shpilberg","year":"2014","journal-title":"Blood"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1158\/1078-0432.CCR-18-3470","article-title":"Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma","volume":"25","author":"Brighton","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1038\/bcj.2017.21","article-title":"A phase 1\/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia","volume":"7","author":"Uy","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1245\/s10434-006-9196-4","article-title":"A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease","volume":"14","author":"Dessureault","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00262-018-2236-7","article-title":"A phase I\/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma","volume":"67","author":"Gray","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Plesca, I., Bene\u0161ov\u00e1, I., Beer, C., Sommer, U., M\u00fcller, L., Wehner, R., Heiduk, M., Aust, D., Baretton, G., and Bachmann, M.P. (2022). Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma. Cancers, 14.","DOI":"10.3390\/cancers14051216"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1158\/1535-7163.MCT-20-0699","article-title":"PGE2 Released by Pancreatic Cancer Cells Undergoing ER Stress Transfers the Stress to DCs Impairing Their Immune Function","volume":"20","author":"Benedetti","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"647","DOI":"10.14348\/molcells.2021.0145","article-title":"Tumour-Derived Reg3A Educates Dendritic Cells to Promote Pancreatic Cancer Progression","volume":"44","author":"Guo","year":"2021","journal-title":"Mol. Cells"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1976952","DOI":"10.1080\/2162402X.2021.1976952","article-title":"Hsp70 modulates immune response in pancreatic cancer through dendritic cells","volume":"10","author":"Giri","year":"2021","journal-title":"Oncoimmunology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00262-020-02746-x","article-title":"Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40\/CD40L on dendritic cells","volume":"70","author":"Sadeghlar","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2006650","DOI":"10.1002\/smll.202006650","article-title":"Immune Stimulating Antibody-Photosensitizer Conjugates via Fc-Mediated Dendritic Cell Phagocytosis and Phototriggered Immunogenic Cell Death for KRAS-Mutated Pancreatic Cancer Treatment","volume":"17","author":"Kim","year":"2021","journal-title":"Small"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"686544","DOI":"10.3389\/fcell.2021.686544","article-title":"Insights into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications","volume":"9","author":"Salah","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3934\/mbe.2022010","article-title":"A TP53-associated immune prognostic signature for the prediction of the overall survival and therapeutic responses in pancreatic cancer","volume":"19","author":"Liu","year":"2022","journal-title":"Math. Biosci. Eng."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1158\/1078-0432.CCR-19-4044","article-title":"A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma","volume":"26","author":"Kandimalla","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/21655979.2020.1860493","article-title":"Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.18632\/aging.102931","article-title":"Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma","volume":"12","author":"Meng","year":"2020","journal-title":"Aging"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"645024","DOI":"10.3389\/fmolb.2021.645024","article-title":"Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12935-021-01824-z","article-title":"Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2018.08.009","article-title":"Immune Cell and Stromal Signature Associated with Progression-Free Survival of Patients with Resected Pancreatic Ductal Adenocarcinoma","volume":"155","author":"Mahajan","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ijc.32186","article-title":"Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes","volume":"145","author":"Yau","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3389\/fimmu.2018.02166","article-title":"The Potential of CAR T Cell Therapy in Pancreatic Cancer","volume":"9","author":"Akce","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/926\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:56:15Z","timestamp":1760136975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":167,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["biomedicines10040926"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10040926","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,4,18]]}}}